{"transactions":[{"id":4638238,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-08T23:03:44.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":false,"shares":26338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":23116,"derivative":{"exercise_price":4.31,"expiration_date":"2028-02-26","underlying":"Common Stock","underlying_shares":26338},"source":{"system":"sec-edgar","filing":"0001610717-26-000434","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000434/form4.xml","form_type":"4"}},{"id":4638237,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-10-08T23:03:44.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":800,"price":38.2626,"value":30610.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on July 7, 2026, in which the majority of the shares acquired upon the exercise of stock options were granted to the Reporting Person prior to the Issuer's initial public offering and are approaching their expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $38.23 to $38.34, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":690695,"source":{"system":"sec-edgar","filing":"0001610717-26-000434","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000434/form4.xml","form_type":"4"}},{"id":4638236,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-10-08T23:03:44.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":25538,"price":37.3869,"value":954786.6522,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on July 7, 2026, in which the majority of the shares acquired upon the exercise of stock options were granted to the Reporting Person prior to the Issuer's initial public offering and are approaching their expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $37.00 to $37.98, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":691495,"source":{"system":"sec-edgar","filing":"0001610717-26-000434","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000434/form4.xml","form_type":"4"}},{"id":4638235,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-10-08T23:03:44.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":true,"shares":26338,"price":4.31,"value":113516.78,"ownership":{"direct":true},"balance_after":717033,"source":{"system":"sec-edgar","filing":"0001610717-26-000434","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000434/form4.xml","form_type":"4"}},{"id":711645,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":31163,"kind":"person","name":"Ruiz Briseno Andres","position":1,"cik":"0001983118","reported_name":"Ruiz Briseno Andres","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-09T20:56:53.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":false,"shares":9550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option is fully vested and exercisable."}],"balance_after":19200,"derivative":{"exercise_price":12.86,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":9550},"source":{"system":"sec-edgar","filing":"0001610717-26-000336","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000336/form4.xml","form_type":"4"}},{"id":711644,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":31163,"kind":"person","name":"Ruiz Briseno Andres","position":1,"cik":"0001983118","reported_name":"Ruiz Briseno Andres","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-09T20:56:53.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":9550,"price":40.0137,"value":382130.835,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $40.00 to $40.10, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":26466,"source":{"system":"sec-edgar","filing":"0001610717-26-000336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000336/form4.xml","form_type":"4"}},{"id":711643,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":31163,"kind":"person","name":"Ruiz Briseno Andres","position":1,"cik":"0001983118","reported_name":"Ruiz Briseno Andres","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-09T20:56:53.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":true,"shares":9550,"price":12.86,"value":122813.0,"ownership":{"direct":true},"balance_after":36016,"source":{"system":"sec-edgar","filing":"0001610717-26-000336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000336/form4.xml","form_type":"4"}},{"id":732183,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":34848,"kind":"person","name":"YARNO WENDY L","position":1,"cik":"0001181186","reported_name":"YARNO WENDY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:34:17.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":30.57,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-26-000265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181186/000161071726000265/form4.xml","form_type":"4"}},{"id":732019,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36795,"kind":"person","name":"Stein Jeffrey","position":1,"cik":"0001478831","reported_name":"Stein Jeffrey","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:33:43.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":30.57,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-26-000264","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478831/000161071726000264/form4.xml","form_type":"4"}},{"id":731955,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36787,"kind":"person","name":"ROSEN TERRY J","position":1,"cik":"0001182473","reported_name":"ROSEN TERRY J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:33:06.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":30.57,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-26-000263","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182473/000161071726000263/form4.xml","form_type":"4"}},{"id":731644,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":34850,"kind":"person","name":"Morrison Scott W","position":1,"cik":"0001662426","reported_name":"Morrison Scott W","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:32:32.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":30.57,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-26-000261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662426/000161071726000261/form4.xml","form_type":"4"}},{"id":731648,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:32:03.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":30.57,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-26-000260","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645330/000161071726000260/form4.xml","form_type":"4"}},{"id":731634,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:31:03.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":30.57,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-26-000259","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000259/form4.xml","form_type":"4"}},{"id":873984,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36795,"kind":"person","name":"Stein Jeffrey","position":1,"cik":"0001478831","reported_name":"Stein Jeffrey","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-03T00:18:09.000Z","date":"2026-03-02","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":32.9578,"value":1647890.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades in prices ranging from $32.743 to $33.1999, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote."}],"balance_after":54281,"source":{"system":"sec-edgar","filing":"0001610717-26-000078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478831/000161071726000078/form4.xml","form_type":"4"}},{"id":924471,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":28562,"kind":"person","name":"Bleharski Joshua","position":1,"cik":"0002075052","reported_name":"Bleharski Joshua","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-03T01:05:22.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2026 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":170000,"derivative":{"exercise_price":32.19,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001610717-26-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000038/form4.xml","form_type":"4"}},{"id":924467,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68160,"kind":"person","name":"WHITE MICHAEL ANTHONY","position":1,"cik":"0001890578","reported_name":"WHITE MICHAEL ANTHONY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-03T01:03:52.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2026 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":190000,"derivative":{"exercise_price":32.19,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001610717-26-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000037/form4.xml","form_type":"4"}},{"id":924470,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68161,"kind":"person","name":"Snyder Douglas B.","position":1,"cik":"0001754125","reported_name":"Snyder Douglas B.","relationship":{"officer":true,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-03T00:57:16.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2026 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":130000,"derivative":{"exercise_price":32.19,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001610717-26-000033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000033/form4.xml","form_type":"4"}},{"id":924469,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68161,"kind":"person","name":"Snyder Douglas B.","position":1,"cik":"0001754125","reported_name":"Snyder Douglas B.","relationship":{"officer":true,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-02-03T00:57:16.000Z","date":"2025-11-28","kind":"grant","planned":false,"acquired":true,"shares":1041,"price":16.9065,"value":17599.6665,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":2080,"source":{"system":"sec-edgar","filing":"0001610717-26-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000033/form4.xml","form_type":"4"}},{"id":924468,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68161,"kind":"person","name":"Snyder Douglas B.","position":1,"cik":"0001754125","reported_name":"Snyder Douglas B.","relationship":{"officer":true,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-02-03T00:57:16.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":1039,"price":16.9065,"value":17565.8535,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1039,"source":{"system":"sec-edgar","filing":"0001610717-26-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000033/form4.xml","form_type":"4"}},{"id":924466,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":31163,"kind":"person","name":"Ruiz Briseno Andres","position":1,"cik":"0001983118","reported_name":"Ruiz Briseno Andres","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-03T00:55:02.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2026 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":80000,"derivative":{"exercise_price":32.19,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001610717-26-000032","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000032/form4.xml","form_type":"4"}},{"id":924465,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":31163,"kind":"person","name":"Ruiz Briseno Andres","position":1,"cik":"0001983118","reported_name":"Ruiz Briseno Andres","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-03T00:55:02.000Z","date":"2025-11-28","kind":"grant","planned":false,"acquired":true,"shares":1253,"price":16.9065,"value":21183.8445,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":26466,"source":{"system":"sec-edgar","filing":"0001610717-26-000032","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000032/form4.xml","form_type":"4"}},{"id":924464,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":31163,"kind":"person","name":"Ruiz Briseno Andres","position":1,"cik":"0001983118","reported_name":"Ruiz Briseno Andres","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-03T00:55:02.000Z","date":"2024-11-29","kind":"grant","planned":false,"acquired":true,"shares":682,"price":23.256,"value":15860.592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":25213,"source":{"system":"sec-edgar","filing":"0001610717-26-000032","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000032/form4.xml","form_type":"4"}},{"id":924531,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68172,"kind":"person","name":"Beaupre Darrin","position":1,"cik":"0001581198","reported_name":"Beaupre Darrin","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-02T20:01:56.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2026 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":175000,"derivative":{"exercise_price":32.19,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001610717-26-000036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581198/000161071726000036/form4.xml","form_type":"4"}},{"id":925570,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68239,"kind":"person","name":"DORMAN STUART","position":1,"cik":"0002047580","reported_name":"DORMAN STUART","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-02T20:00:11.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2026 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":155000,"derivative":{"exercise_price":32.19,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001610717-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047580/000161071726000035/form4.xml","form_type":"4"}},{"id":924920,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-02T19:58:51.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2026 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":600000,"derivative":{"exercise_price":32.19,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001610717-26-000034","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071726000034/form4.xml","form_type":"4"}},{"id":1101100,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":34848,"kind":"person","name":"YARNO WENDY L","position":1,"cik":"0001181186","reported_name":"YARNO WENDY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T20:57:37.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":21.78,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-25-000265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181186/000161071725000265/form4.xml","form_type":"4"}},{"id":1101033,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36795,"kind":"person","name":"Stein Jeffrey","position":1,"cik":"0001478831","reported_name":"Stein Jeffrey","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T20:56:47.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":21.78,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-25-000264","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478831/000161071725000264/form4.xml","form_type":"4"}},{"id":1100793,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T20:56:12.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":21.78,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-25-000263","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071725000263/form4.xml","form_type":"4"}},{"id":1100799,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":34850,"kind":"person","name":"Morrison Scott W","position":1,"cik":"0001662426","reported_name":"Morrison Scott W","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T20:55:36.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":21.78,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-25-000262","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662426/000161071725000262/form4.xml","form_type":"4"}},{"id":1100801,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T20:54:45.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":21.78,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-25-000261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645330/000161071725000261/form4.xml","form_type":"4"}},{"id":1101017,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36787,"kind":"person","name":"ROSEN TERRY J","position":1,"cik":"0001182473","reported_name":"ROSEN TERRY J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T20:54:04.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":21.78,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-25-000260","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182473/000161071725000260/form4.xml","form_type":"4"}},{"id":1237859,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":31163,"kind":"person","name":"Ruiz Briseno Andres","position":1,"cik":"0001983118","reported_name":"Ruiz Briseno Andres","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-28T23:02:04.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":75000,"derivative":{"exercise_price":20.24,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001610717-25-000041","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071725000041/form4.xml","form_type":"4"}},{"id":1237858,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68160,"kind":"person","name":"WHITE MICHAEL ANTHONY","position":1,"cik":"0001890578","reported_name":"WHITE MICHAEL ANTHONY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-28T23:01:16.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":185000,"derivative":{"exercise_price":20.24,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001610717-25-000040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071725000040/form4.xml","form_type":"4"}},{"id":1237856,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68161,"kind":"person","name":"Snyder Douglas B.","position":1,"cik":"0001754125","reported_name":"Snyder Douglas B.","relationship":{"officer":true,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-28T23:00:54.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":33000,"derivative":{"exercise_price":20.24,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001610717-25-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071725000039/form4.xml","form_type":"4"}},{"id":1237912,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68172,"kind":"person","name":"Beaupre Darrin","position":1,"cik":"0001581198","reported_name":"Beaupre Darrin","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-28T18:03:47.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":185000,"derivative":{"exercise_price":20.24,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001610717-25-000043","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581198/000161071725000043/form4.xml","form_type":"4"}},{"id":1238888,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68239,"kind":"person","name":"DORMAN STUART","position":1,"cik":"0002047580","reported_name":"DORMAN STUART","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-28T18:02:27.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":15000,"derivative":{"exercise_price":20.24,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001610717-25-000042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047580/000161071725000042/form4.xml","form_type":"4"}},{"id":1238510,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-28T18:00:28.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":600000,"derivative":{"exercise_price":20.24,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001610717-25-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071725000038/form4.xml","form_type":"4"}},{"id":1259884,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-19T06:00:15.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":false,"shares":12808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":182192,"derivative":{"exercise_price":19.52,"expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":12808},"source":{"system":"sec-edgar","filing":"0001610717-25-000021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071725000021/form4.xml","form_type":"4"}},{"id":1259883,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-19T06:00:15.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":true,"shares":12808,"price":19.52,"value":250012.16,"ownership":{"direct":true},"balance_after":690695,"source":{"system":"sec-edgar","filing":"0001610717-25-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071725000021/form4.xml","form_type":"4"}},{"id":1398340,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68161,"kind":"person","name":"Snyder Douglas B.","position":1,"cik":"0001754125","reported_name":"Snyder Douglas B.","relationship":{"officer":true,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-27T20:25:26.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from September 18, 2024 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":140000,"derivative":{"exercise_price":30.5,"expiration_date":"2034-09-25","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001610717-24-000497","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000497/form4.xml","form_type":"4"}},{"id":1467939,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":89465,"kind":"person","name":"Throne Jason","position":1,"cik":"0001790865","reported_name":"Throne Jason","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T22:47:10.000Z","date":"2024-06-27","kind":"exercise","planned":false,"acquired":false,"shares":47060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":1360,"derivative":{"exercise_price":7.01,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":47060},"source":{"system":"sec-edgar","filing":"0001610717-24-000367","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000367/form4.xml","form_type":"4"}},{"id":1467938,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":89465,"kind":"person","name":"Throne Jason","position":1,"cik":"0001790865","reported_name":"Throne Jason","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T22:47:10.000Z","date":"2024-06-27","kind":"exercise","planned":false,"acquired":false,"shares":6424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from July 1, 2020 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":41186,"derivative":{"exercise_price":13.34,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":6424},"source":{"system":"sec-edgar","filing":"0001610717-24-000367","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000367/form4.xml","form_type":"4"}},{"id":1467937,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":89465,"kind":"person","name":"Throne Jason","position":1,"cik":"0001790865","reported_name":"Throne Jason","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-06-27T22:47:10.000Z","date":"2024-06-27","kind":"exercise","planned":false,"acquired":true,"shares":47060,"price":7.01,"value":329890.6,"ownership":{"direct":true},"balance_after":63484,"source":{"system":"sec-edgar","filing":"0001610717-24-000367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000367/form4.xml","form_type":"4"}},{"id":1467936,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":89465,"kind":"person","name":"Throne Jason","position":1,"cik":"0001790865","reported_name":"Throne Jason","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-06-27T22:47:10.000Z","date":"2024-06-27","kind":"exercise","planned":false,"acquired":true,"shares":6424,"price":13.34,"value":85696.16,"ownership":{"direct":true},"balance_after":16424,"source":{"system":"sec-edgar","filing":"0001610717-24-000367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000367/form4.xml","form_type":"4"}},{"id":1496618,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36787,"kind":"person","name":"ROSEN TERRY J","position":1,"cik":"0001182473","reported_name":"ROSEN TERRY J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T20:38:35.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":16200,"derivative":{"exercise_price":36.55,"expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001610717-24-000279","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182473/000161071724000279/form4.xml","form_type":"4"}},{"id":1496367,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":32782,"kind":"person","name":"Kelley Susan L.","position":1,"cik":"0001519612","reported_name":"Kelley Susan L.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T20:38:32.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":16200,"derivative":{"exercise_price":36.55,"expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001610717-24-000278","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1519612/000161071724000278/form4.xml","form_type":"4"}},{"id":1496292,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T20:38:29.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":16200,"derivative":{"exercise_price":36.55,"expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001610717-24-000277","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000277/form4.xml","form_type":"4"}},{"id":1496654,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36795,"kind":"person","name":"Stein Jeffrey","position":1,"cik":"0001478831","reported_name":"Stein Jeffrey","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T20:38:25.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":16200,"derivative":{"exercise_price":36.55,"expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001610717-24-000276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478831/000161071724000276/form4.xml","form_type":"4"}},{"id":1496294,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":34850,"kind":"person","name":"Morrison Scott W","position":1,"cik":"0001662426","reported_name":"Morrison Scott W","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T20:38:19.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":16200,"derivative":{"exercise_price":36.55,"expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001610717-24-000275","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662426/000161071724000275/form4.xml","form_type":"4"}},{"id":1496770,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":34848,"kind":"person","name":"YARNO WENDY L","position":1,"cik":"0001181186","reported_name":"YARNO WENDY L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T20:31:24.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":16200,"derivative":{"exercise_price":36.55,"expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001610717-24-000274","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181186/000161071724000274/form4.xml","form_type":"4"}},{"id":1496297,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T20:30:21.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":16200,"derivative":{"exercise_price":36.55,"expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001610717-24-000273","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645330/000161071724000273/form4.xml","form_type":"4"}},{"id":1496291,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68160,"kind":"person","name":"WHITE MICHAEL ANTHONY","position":1,"cik":"0001890578","reported_name":"WHITE MICHAEL ANTHONY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T20:26:47.000Z","date":"2024-05-29","kind":"exercise","planned":true,"acquired":false,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":64000,"derivative":{"exercise_price":12.86,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001610717-24-000272","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000272/form4.xml","form_type":"4"}},{"id":1496290,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68160,"kind":"person","name":"WHITE MICHAEL ANTHONY","position":1,"cik":"0001890578","reported_name":"WHITE MICHAEL ANTHONY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-31T20:26:47.000Z","date":"2024-05-29","kind":"sale","planned":true,"acquired":false,"shares":851,"price":36.7763,"value":31296.6313,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on February 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $36.68 to $36.81, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001610717-24-000272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000272/form4.xml","form_type":"4"}},{"id":1496289,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68160,"kind":"person","name":"WHITE MICHAEL ANTHONY","position":1,"cik":"0001890578","reported_name":"WHITE MICHAEL ANTHONY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-31T20:26:47.000Z","date":"2024-05-29","kind":"sale","planned":true,"acquired":false,"shares":27649,"price":36.2251,"value":1001587.7899,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on February 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $35.68 to $36.655, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":851,"source":{"system":"sec-edgar","filing":"0001610717-24-000272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000272/form4.xml","form_type":"4"}},{"id":1496288,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68160,"kind":"person","name":"WHITE MICHAEL ANTHONY","position":1,"cik":"0001890578","reported_name":"WHITE MICHAEL ANTHONY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-31T20:26:47.000Z","date":"2024-05-29","kind":"exercise","planned":true,"acquired":true,"shares":28500,"price":12.86,"value":366510.0,"ownership":{"direct":true},"balance_after":28500,"source":{"system":"sec-edgar","filing":"0001610717-24-000272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000272/form4.xml","form_type":"4"}},{"id":1514253,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-16T17:51:24.000Z","date":"2024-05-16","kind":"exercise","planned":true,"acquired":false,"shares":34433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":49454,"derivative":{"exercise_price":4.31,"expiration_date":"2028-02-26","underlying":"Common Stock","underlying_shares":34433},"source":{"system":"sec-edgar","filing":"0001610717-24-000239","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000239/form4.xml","form_type":"4"}},{"id":1514252,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-16T17:51:24.000Z","date":"2024-05-15","kind":"exercise","planned":true,"acquired":false,"shares":83856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":83887,"derivative":{"exercise_price":4.31,"expiration_date":"2028-02-26","underlying":"Common Stock","underlying_shares":83856},"source":{"system":"sec-edgar","filing":"0001610717-24-000239","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000239/form4.xml","form_type":"4"}},{"id":1514251,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-16T17:51:24.000Z","date":"2024-05-14","kind":"exercise","planned":true,"acquired":false,"shares":56711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":167743,"derivative":{"exercise_price":4.31,"expiration_date":"2028-02-26","underlying":"Common Stock","underlying_shares":56711},"source":{"system":"sec-edgar","filing":"0001610717-24-000239","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000239/form4.xml","form_type":"4"}},{"id":1514250,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-16T17:51:24.000Z","date":"2024-05-16","kind":"sale","planned":true,"acquired":false,"shares":4349,"price":42.366,"value":184249.734,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades in prices ranging from $42.26 to $42.595, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":677887,"source":{"system":"sec-edgar","filing":"0001610717-24-000239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000239/form4.xml","form_type":"4"}},{"id":1514249,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-16T17:51:24.000Z","date":"2024-05-16","kind":"sale","planned":true,"acquired":false,"shares":30084,"price":41.7333,"value":1255504.5972,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades in prices ranging from $41.2651 to $42.25, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":682236,"source":{"system":"sec-edgar","filing":"0001610717-24-000239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000239/form4.xml","form_type":"4"}},{"id":1514248,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-16T17:51:24.000Z","date":"2024-05-16","kind":"exercise","planned":true,"acquired":true,"shares":34433,"price":4.31,"value":148406.23,"ownership":{"direct":true},"balance_after":712320,"source":{"system":"sec-edgar","filing":"0001610717-24-000239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000239/form4.xml","form_type":"4"}},{"id":1514247,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-16T17:51:24.000Z","date":"2024-05-15","kind":"sale","planned":true,"acquired":false,"shares":503,"price":44.1179,"value":22191.3037,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades in prices ranging from $44.10 to $44.14, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":677887,"source":{"system":"sec-edgar","filing":"0001610717-24-000239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000239/form4.xml","form_type":"4"}},{"id":1514246,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-16T17:51:24.000Z","date":"2024-05-15","kind":"sale","planned":true,"acquired":false,"shares":29761,"price":43.4775,"value":1293933.8775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades in prices ranging from $43.09 to $43.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":678390,"source":{"system":"sec-edgar","filing":"0001610717-24-000239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000239/form4.xml","form_type":"4"}},{"id":1514245,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-16T17:51:24.000Z","date":"2024-05-15","kind":"sale","planned":true,"acquired":false,"shares":53592,"price":42.5741,"value":2281631.1672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $42.08 to $43.07, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":708151,"source":{"system":"sec-edgar","filing":"0001610717-24-000239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000239/form4.xml","form_type":"4"}},{"id":1514244,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-16T17:51:24.000Z","date":"2024-05-15","kind":"exercise","planned":true,"acquired":true,"shares":83856,"price":4.31,"value":361419.36,"ownership":{"direct":true},"balance_after":761743,"source":{"system":"sec-edgar","filing":"0001610717-24-000239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000239/form4.xml","form_type":"4"}},{"id":1514243,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-16T17:51:24.000Z","date":"2024-05-14","kind":"sale","planned":true,"acquired":false,"shares":2303,"price":41.8357,"value":96347.6171,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $41.81 to $41.945, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":677887,"source":{"system":"sec-edgar","filing":"0001610717-24-000239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000239/form4.xml","form_type":"4"}},{"id":1514242,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-16T17:51:24.000Z","date":"2024-05-14","kind":"sale","planned":true,"acquired":false,"shares":54408,"price":41.6011,"value":2263432.6488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $40.815 to $41.80, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":680190,"source":{"system":"sec-edgar","filing":"0001610717-24-000239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000239/form4.xml","form_type":"4"}},{"id":1514241,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-16T17:51:24.000Z","date":"2024-05-14","kind":"exercise","planned":true,"acquired":true,"shares":56711,"price":4.31,"value":244424.41,"ownership":{"direct":true},"balance_after":734598,"source":{"system":"sec-edgar","filing":"0001610717-24-000239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000239/form4.xml","form_type":"4"}},{"id":1602270,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":31163,"kind":"person","name":"Ruiz Briseno Andres","position":1,"cik":"0001983118","reported_name":"Ruiz Briseno Andres","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-04T22:27:48.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2024 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":85000,"derivative":{"exercise_price":46.22,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001610717-24-000119","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000119/form4.xml","form_type":"4"}},{"id":1602269,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68160,"kind":"person","name":"WHITE MICHAEL ANTHONY","position":1,"cik":"0001890578","reported_name":"WHITE MICHAEL ANTHONY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-04T22:26:08.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2024 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":140000,"derivative":{"exercise_price":46.22,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001610717-24-000117","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000117/form4.xml","form_type":"4"}},{"id":1602267,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":89465,"kind":"person","name":"Throne Jason","position":1,"cik":"0001790865","reported_name":"Throne Jason","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-04T22:24:52.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":125500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2024 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":125500,"derivative":{"exercise_price":46.22,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":125500},"source":{"system":"sec-edgar","filing":"0001610717-24-000116","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000116/form4.xml","form_type":"4"}},{"id":1603079,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-04T17:28:31.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":480000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2024 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":480000,"derivative":{"exercise_price":46.22,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":480000},"source":{"system":"sec-edgar","filing":"0001610717-24-000120","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000120/form4.xml","form_type":"4"}},{"id":1602378,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":68172,"kind":"person","name":"Beaupre Darrin","position":1,"cik":"0001581198","reported_name":"Beaupre Darrin","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-04T17:27:00.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2024 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":160000,"derivative":{"exercise_price":46.22,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001610717-24-000118","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581198/000161071724000118/form4.xml","form_type":"4"}},{"id":1645287,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":31163,"kind":"person","name":"Ruiz Briseno Andres","position":1,"cik":"0001983118","reported_name":"Ruiz Briseno Andres","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-13T21:59:54.000Z","date":"2024-02-09","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":46.0223,"value":92044.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $46.00 to $46.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":24531,"source":{"system":"sec-edgar","filing":"0001610717-24-000059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000059/form4.xml","form_type":"4"}},{"id":1649193,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-12T16:27:58.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":false,"shares":23557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":224454,"derivative":{"exercise_price":4.31,"expiration_date":"2028-02-26","underlying":"Common Stock","underlying_shares":23557},"source":{"system":"sec-edgar","filing":"0001610717-24-000053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000053/form4.xml","form_type":"4"}},{"id":1649192,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-12T16:27:58.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":false,"shares":75815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":248011,"derivative":{"exercise_price":4.31,"expiration_date":"2028-02-26","underlying":"Common Stock","underlying_shares":75815},"source":{"system":"sec-edgar","filing":"0001610717-24-000053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000053/form4.xml","form_type":"4"}},{"id":1649191,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-12T16:27:58.000Z","date":"2024-02-09","kind":"sale","planned":true,"acquired":false,"shares":23557,"price":45.537,"value":1072715.109,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $45.01 to $45.82, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":677887,"source":{"system":"sec-edgar","filing":"0001610717-24-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000053/form4.xml","form_type":"4"}},{"id":1649190,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-12T16:27:58.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":true,"shares":23557,"price":4.31,"value":101530.67,"ownership":{"direct":true},"balance_after":701444,"source":{"system":"sec-edgar","filing":"0001610717-24-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000053/form4.xml","form_type":"4"}},{"id":1649189,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-12T16:27:58.000Z","date":"2024-02-08","kind":"sale","planned":true,"acquired":false,"shares":75815,"price":45.1472,"value":3422834.968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $45.00 to $45.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":677887,"source":{"system":"sec-edgar","filing":"0001610717-24-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000053/form4.xml","form_type":"4"}},{"id":1649188,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-12T16:27:58.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":true,"shares":75815,"price":4.31,"value":326762.65,"ownership":{"direct":true},"balance_after":753702,"source":{"system":"sec-edgar","filing":"0001610717-24-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000053/form4.xml","form_type":"4"}},{"id":1658870,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-05T18:05:39.000Z","date":"2024-02-01","kind":"exercise","planned":true,"acquired":false,"shares":628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":323826,"derivative":{"exercise_price":4.31,"expiration_date":"2028-02-26","underlying":"Common Stock","underlying_shares":628},"source":{"system":"sec-edgar","filing":"0001610717-24-000043","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000043/form4.xml","form_type":"4"}},{"id":1658869,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-05T18:05:39.000Z","date":"2024-02-01","kind":"sale","planned":true,"acquired":false,"shares":4,"price":45.01,"value":180.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 11, 2023."}],"balance_after":677887,"source":{"system":"sec-edgar","filing":"0001610717-24-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000043/form4.xml","form_type":"4"}},{"id":1658868,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-05T18:05:39.000Z","date":"2024-02-01","kind":"sale","planned":true,"acquired":false,"shares":624,"price":45,"value":28080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 11, 2023."}],"balance_after":677891,"source":{"system":"sec-edgar","filing":"0001610717-24-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000043/form4.xml","form_type":"4"}},{"id":1658867,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-05T18:05:39.000Z","date":"2024-02-01","kind":"exercise","planned":true,"acquired":true,"shares":628,"price":4.31,"value":2706.68,"ownership":{"direct":true},"balance_after":678515,"source":{"system":"sec-edgar","filing":"0001610717-24-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000043/form4.xml","form_type":"4"}},{"id":1671831,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":31163,"kind":"person","name":"Ruiz Briseno Andres","position":1,"cik":"0001983118","reported_name":"Ruiz Briseno Andres","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-25T00:12:09.000Z","date":"2024-01-22","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":42.0251,"value":84050.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $42.00 to $42.07, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":26531,"source":{"system":"sec-edgar","filing":"0001610717-24-000041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000041/form4.xml","form_type":"4"}},{"id":1677509,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":31163,"kind":"person","name":"Ruiz Briseno Andres","position":1,"cik":"0001983118","reported_name":"Ruiz Briseno Andres","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-17T22:41:04.000Z","date":"2024-01-12","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":38.0128,"value":76025.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $38.00 to $38.02, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":28531,"source":{"system":"sec-edgar","filing":"0001610717-24-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000029/form4.xml","form_type":"4"}},{"id":1677879,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-17T17:40:01.000Z","date":"2024-01-16","kind":"exercise","planned":true,"acquired":false,"shares":62739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":324454,"derivative":{"exercise_price":4.31,"expiration_date":"2028-02-26","underlying":"Common Stock","underlying_shares":62739},"source":{"system":"sec-edgar","filing":"0001610717-24-000028","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000028/form4.xml","form_type":"4"}},{"id":1677878,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-17T17:40:01.000Z","date":"2024-01-12","kind":"exercise","planned":true,"acquired":false,"shares":12261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":387193,"derivative":{"exercise_price":4.31,"expiration_date":"2028-02-26","underlying":"Common Stock","underlying_shares":12261},"source":{"system":"sec-edgar","filing":"0001610717-24-000028","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000028/form4.xml","form_type":"4"}},{"id":1677877,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-17T17:40:01.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":62739,"price":40.1659,"value":2519968.4001,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $40.00 to $40.27, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":677887,"source":{"system":"sec-edgar","filing":"0001610717-24-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000028/form4.xml","form_type":"4"}},{"id":1677876,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-17T17:40:01.000Z","date":"2024-01-16","kind":"exercise","planned":true,"acquired":true,"shares":62739,"price":4.31,"value":270405.09,"ownership":{"direct":true},"balance_after":740626,"source":{"system":"sec-edgar","filing":"0001610717-24-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000028/form4.xml","form_type":"4"}},{"id":1677875,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-17T17:40:01.000Z","date":"2024-01-12","kind":"sale","planned":true,"acquired":false,"shares":12261,"price":40.0386,"value":490913.2746,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $40.00 to $40.08, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":677887,"source":{"system":"sec-edgar","filing":"0001610717-24-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000028/form4.xml","form_type":"4"}},{"id":1677874,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-17T17:40:01.000Z","date":"2024-01-12","kind":"exercise","planned":true,"acquired":true,"shares":12261,"price":4.31,"value":52844.91,"ownership":{"direct":true},"balance_after":690148,"source":{"system":"sec-edgar","filing":"0001610717-24-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071724000028/form4.xml","form_type":"4"}},{"id":1704176,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":89465,"kind":"person","name":"Throne Jason","position":1,"cik":"0001790865","reported_name":"Throne Jason","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T22:37:12.000Z","date":"2023-12-18","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":48420,"derivative":{"exercise_price":7.01,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001610717-23-000406","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071723000406/form4.xml","form_type":"4"}},{"id":1704175,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":89465,"kind":"person","name":"Throne Jason","position":1,"cik":"0001790865","reported_name":"Throne Jason","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T22:37:12.000Z","date":"2023-12-15","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on the first anniversary measured from July 1, 2020 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":47610,"derivative":{"exercise_price":13.34,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001610717-23-000406","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071723000406/form4.xml","form_type":"4"}},{"id":1704174,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":89465,"kind":"person","name":"Throne Jason","position":1,"cik":"0001790865","reported_name":"Throne Jason","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-12-19T22:37:12.000Z","date":"2023-12-18","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":7.01,"value":70100.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001610717-23-000406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071723000406/form4.xml","form_type":"4"}},{"id":1704173,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":89465,"kind":"person","name":"Throne Jason","position":1,"cik":"0001790865","reported_name":"Throne Jason","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-12-19T22:37:12.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":35.0371,"value":350371.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $35.00 to $35.10, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001610717-23-000406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071723000406/form4.xml","form_type":"4"}},{"id":1704172,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":89465,"kind":"person","name":"Throne Jason","position":1,"cik":"0001790865","reported_name":"Throne Jason","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-12-19T22:37:12.000Z","date":"2023-12-15","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":13.34,"value":133400.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001610717-23-000406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071723000406/form4.xml","form_type":"4"}},{"id":1704855,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-12-19T17:34:13.000Z","date":"2023-12-15","kind":"exercise","planned":true,"acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":399454,"derivative":{"exercise_price":4.31,"expiration_date":"2028-02-26","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001610717-23-000405","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071723000405/form4.xml","form_type":"4"}},{"id":1704854,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-19T17:34:13.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":75000,"price":35.0349,"value":2627617.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $35.00 to $35.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":677887,"source":{"system":"sec-edgar","filing":"0001610717-23-000405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071723000405/form4.xml","form_type":"4"}},{"id":1704853,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":61040,"kind":"person","name":"Hata Yujiro S","position":1,"cik":"0001649119","reported_name":"Hata Yujiro S","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-19T17:34:13.000Z","date":"2023-12-15","kind":"exercise","planned":true,"acquired":true,"shares":75000,"price":4.31,"value":323250.0,"ownership":{"direct":true},"balance_after":752887,"source":{"system":"sec-edgar","filing":"0001610717-23-000405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649119/000161071723000405/form4.xml","form_type":"4"}}],"next_cursor":"2023-12-19T17:34:13.000000Z,1704853"}